- Home
- CTXR vs EDSA Comparison
CTXR vs EDSA Comparison
Compare CTXR & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- EDSA
- Stock Information
- Founded
- CTXR 2007
- EDSA 2015
- Country
- CTXR United States
- EDSA Canada
- Employees
- CTXR N/A
- EDSA N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- CTXR Health Care
- EDSA Health Care
- Exchange
- CTXR Nasdaq
- EDSA Nasdaq
- Market Cap
- CTXR 23.0M
- EDSA 15.4M
- IPO Year
- CTXR N/A
- EDSA N/A
- Fundamental
- Price
- CTXR $1.33
- EDSA $2.32
- Analyst Decision
- CTXR Strong Buy
- EDSA Strong Buy
- Analyst Count
- CTXR 3
- EDSA 2
- Target Price
- CTXR $53.00
- EDSA $13.00
- AVG Volume (30 Days)
- CTXR 443.9K
- EDSA 21.1K
- Earning Date
- CTXR 08-12-2025
- EDSA 08-08-2025
- Dividend Yield
- CTXR N/A
- EDSA N/A
- EPS Growth
- CTXR N/A
- EDSA N/A
- EPS
- CTXR N/A
- EDSA N/A
- Revenue
- CTXR N/A
- EDSA N/A
- Revenue This Year
- CTXR N/A
- EDSA N/A
- Revenue Next Year
- CTXR $851.67
- EDSA N/A
- P/E Ratio
- CTXR N/A
- EDSA N/A
- Revenue Growth
- CTXR N/A
- EDSA N/A
- 52 Week Low
- CTXR $0.65
- EDSA $1.55
- 52 Week High
- CTXR $15.25
- EDSA $5.00
- Technical
- Relative Strength Index (RSI)
- CTXR 48.91
- EDSA 60.67
- Support Level
- CTXR $1.23
- EDSA $2.33
- Resistance Level
- CTXR $1.43
- EDSA $2.55
- Average True Range (ATR)
- CTXR 0.11
- EDSA 0.13
- MACD
- CTXR 0.01
- EDSA 0.01
- Stochastic Oscillator
- CTXR 38.46
- EDSA 64.44
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.